Home » Market News » DirectorsTalk Highlights » What is immunotherapy’s relationship to the immune system?
Avacta Group Plc

What is immunotherapy’s relationship to the immune system?

Immunotherapy can:

  • Educate the immune system to recognize and attack specific cancer cells
  • Boost immune cells to help them eliminate cancer
  • Provide the body with additional components to enhance the immune response

Cancer immunotherapy comes in a variety of forms, including targeted antibodies, cancer vaccines, adoptive cell transfer, tumor-infecting viruses, checkpoint inhibitors, cytokines, and adjuvants. Immunotherapies are a form of biotherapy (also called biologic therapy or biological response modifier (BRM) therapy) because they use materials from living organisms to fight disease.

Avacta Group Plc (LON:AVCT) offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. The company’s custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.